| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.097 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.029 | 0.6 |